Targeted Therapy
Brand names:
VitrakviÒ
Other names:
Larotrectinib Sulfate; LOXO-101; TRK Inhibitor LOXO-101
Often used for:
Solid tumors
Larotrectinib (VitrakviÒ) is a type of medicine called a targeted therapy. This medicine is a tropomysin receptor kinase (TRK) inhibitor. It acts to block certain cell signals that may help keep cancer cells from growing. Larotrectinib is used to treat some solid tumors.
Patients will have regular blood draws to check blood counts and to monitor liver and kidney function.
May be given as a capsule by mouth
May be given as a liquid by mouth
Not all patients who take larotrectinib will experience these side effects. Common side effects are in bold, but there may be others. Please report all suspected side effects to your doctor or pharmacist.
Be sure to discuss these and other recommendations with your doctor or pharmacist.
Always check the medication label. Many medicines look the same. Do not take any new medicine, including over-the counter medicines or supplements, without checking with your doctor or pharmacist. Talk to your doctor or pharmacist about what to do in the case of a missed dose, allergic reaction, or medical emergency. This information is not intended to be a complete guide and is not a substitute for talking with your provider.